IDP-120 Gel

DRUG5 trials

Sponsors

Valeant Pharmaceuticals, Bausch Health Americas, Inc.

Conditions

AcneAcne Vulgaris

Phase 1

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

CompletedNCT02850003

Bausch Health Americas, Inc.Acne

Start: 2016-06-30End: 2016-11-30Updated: 2017-09-25

Phase 2

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Valeant PharmaceuticalsAcne Vulgaris

Start: 2015-10-31End: 2016-09-30Target: 350Updated: 2015-09-14

Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

CompletedNCT03003247

Bausch Health Americas, Inc.Acne Vulgaris

Start: 2015-11-30End: 2016-09-30Updated: 2017-12-18

Phase 3

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

CompletedNCT03664752

Bausch Health Americas, Inc.Acne Vulgaris

Start: 2018-12-10End: 2020-05-07Updated: 2023-03-29

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

CompletedNCT03664739

Bausch Health Americas, Inc.Acne Vulgaris

Start: 2018-12-05End: 2020-03-23Updated: 2023-03-29